Methyl (3aR,5R,6R,6aR)-6-bromo-2-oxohexahydro-2H-cyclopenta[d]oxazole-5-carboxylate

Catalog No. :
ACLZFU849
CAS No. :
352226-71-2
Molecular Formula :
C8H10BrNO4
Molecular Weight :
264.08

IUPAC Name:methyl (3aR,5R,6R,6aR)-6-bromo-2-oxohexahydro-2H-cyclopenta[d]oxazole-5-carboxylate

Methyl (3aR,5R,6R,6aR)-6-bromo-2-oxohexahydro-2H-cyclopenta[d]oxazole-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$563.00Login to see priceInquiryInquiry
250mg95%$937.00Login to see priceInquiryInquiry
500mg95%$1339.00Login to see priceInquiryInquiry
1g95%$1912.00Login to see priceInquiryInquiry
5g95%$5735.00Login to see priceInquiryInquiry
10g95%$9558.00Login to see priceInquiryInquiry
25g95%$19115.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl (3aR,5R,6R,6aR)-6-bromo-2-oxohexahydro-2H-cyclopenta[d]oxazole-5-carboxylate
IUPAC Namemethyl (3aR,5R,6R,6aR)-6-bromo-2-oxohexahydro-2H-cyclopenta[d]oxazole-5-carboxylate
Molecular FormulaC8H10BrNO4
Molecular Weight264.08
SMILESBr[C@H]1[C@@]2([H])[C@@](NC(O2)=O)([H])C[C@@H]1C(OC)=O
InChI KeyLJSQJYRZBVEIJZ-SLPGGIOYSA-N
Synonym2H-Cyclopentoxazole-5-carboxylic acid, 6-bromohexahydro-2-oxo-, methyl ester, (3aR,5R,6R,6aR)-;methyl (3aR,5R,6R,6aR)-6-bromo-2-oxo-3,3a,4,5,6,6a-hexahydrocyclopenta[d]oxazole-5-carboxylate
CAS No.352226-71-2

Synthetic Route by SureRoute

1. ACLZFU849 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZVOL176 route compound structure diagram
    ACZVOL176168683-02-1 In Stock
  2. Then
  3. ACLZFU849 route product structure diagram
    ACLZFU849352226-71-2
Inquiry

2. ACLZFU849 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLZFU849 route product structure diagram
    ACLZFU849352226-71-2
Inquiry

Comments (0)